Published in
Nature Research, Nature Biotechnology, 9(23), p. 1047-1049, 2005
DOI: 10.1038/nbt0905-1047
Links
Tools
Empowering the inventor - the case of monoclonal antibodies
Journal article published in 2005 by
Mike Clark 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Academic ownership of intellectual property facilitated wide dissemination and commercialization of antibody technology. Moves at the University of Cambridge to reclaim institutional IP rights should thus be treated with caution.